Clinical trial · Interventional
Peri-operative Vitamin D Therapy for Hepatectomy
Peri-operative Vitamin D Therapy for Patients With Hepatocellular Carcinoma Receiving Hepatectomy
NCT05650151CI-TRIAL-00062687unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this double-blind, randomized controlled trial is to test the effect of short-term and high-dose vitamin D therapy in patients undergoing hepatectomy for hepatocellular carcinoma.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hepatocellular Carcinoma | Hepatocellular Carcinoma | ONTOLOGY_EXACT | 0.98 |
| Perioperative Complication | — | UNRESOLVED | — |
| Vitamin D Deficiency | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Placebo | Dietary Supplement | — | UNRESOLVED |
| Vitamin D | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Vitamin D group
- interventionNames
- Dietary Supplement: Vitamin D
- type
- PLACEBO_COMPARATOR
- label
- Control group
- interventionNames
- Dietary Supplement: Placebo
Primary outcomes (1)
- measure
- Infection rate
- timeFrame
- Perioperative period
- description
- Diagnosed by clinical presentation and relevant biomarker
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
Show eligibility criteria text
Inclusion Criteria: * Patients older than 20 years * Patients will undergo hepatectomy for hepatocellular carcinoma. Exclusion Criteria: * Patients with hypercalcemia, hyperparathyroidism, sarcoidosis, multiple myeloma
References
Publications (0)
Data not yet available
No reference posted for this study.